抑癌基因DKK2抑制儿童肾母细胞瘤细胞增殖的机制研究

doi:10.11904/j.issn.1002-3070.2019.01.003

摘要/Abstract

摘要： 目的探讨WNT信号通路调控因子DKK2在儿童肾母细胞瘤细胞和组织中的表达,及对儿童肾母细胞瘤细胞SK-NEP-1增殖的影响,并初步探讨其作用机制。方法通过RT-PCR、qRT-PCR和免疫蛋白印迹实验分析DKK2在儿童肾母细胞瘤细胞系和组织中的相对表达;将DKK2过表达的SK-NEP-1细胞设定为实验组(DKK2组),空白对照质粒组设定为对照组(Vector组),分别转染pcDNA3.1(+)-Flag-DKK2质粒(实验组)和pcDNA3.1(+)-Flag-Vector质粒(对照组)至SK-NEP-1细胞系,RT-PCR和免疫蛋白印迹实验验证DKK2的过表达;通过CCK-8实验和细胞克隆实验分析DKK2对细胞增殖的影响;流式细胞周期和凋亡实验验证DKK2过表达对细胞增殖的作用机制;裸鼠成瘤实验验证DKK2体外对细胞增殖的影响;通过qRT-PCR、WB及免疫组化分析DKK2对细胞增殖抑制的作用机制。结果与正常肾上皮组织相比,DKK2 mRNA在儿童肾母细胞瘤细胞和组织中的中表达明显下调,差异具有统计学意义(P＜0.001);与对照组相比(100%),转染后24、48、72h实验组细胞活性受到明显的抑制(P＜0.05),同时实验组细胞克隆形成明显受到抑制(31.11±2.14)%(P＜0.05);流式细胞实验发现,与对照组相比,实验组细胞明显阻滞于G₁期(P＜0.001),实验组中细胞凋亡率明显升高(P＜0.001);与对照组相比,过表达DKK2后裸鼠肿瘤和体积大小明显降低(P＜0.001);过表达DKK2后,active-β-catenin及下游的基因受到了明显抑制。结论 DKK2在人皮肤肾母细胞瘤组织中表达下调,可能通过拮抗Wnt/β-catenin信号通路参与肾母细胞瘤的机制。

关键词: 儿童肾母细胞瘤, DKK2, 抑癌基因, 细胞增殖, Wnt/β-catenin

Abstract: Objective The aims of this study were to investigate the expression of DKK2,a WNT signaling pathway regulator,in nephroblastoma cells and tissues of children,the effect on the proliferation of nephroblastoma SK-NEP-1 cells,and to explore its mechanism.Methods The relative expression of DKK2 in nephroblastoma cells and tissues was analyzed by qRT-PCR and immunoblotting assays.Overexpressing DKK2 SK-NEP-1 cells were set as the experimental group(DKK2 group);the blank control plasmid group was set as a control group(Vector group),transfected with pcDNA3.1(+)-Flag-DKK2 plasmid(Experimental group)and pcDNA3.1(+)-Flag-Vector plasmid(Control group).The over-expression of DKK2 was confirmed in SK-NEP-1 cells by RT-PCR and immunoblotting.CCK-8 and cell cloning assays were used to determine the effect of DKK2 on cell proliferation;flow cell cycle and apoptosis assays were used to confirm the effect on cell proliferation in overexpressed DKK2 cells.The xengraft formation assay in nude mice was to verify the effect of DKK2 on proliferation in overexpressed DKK2 cells;the mechanism of DKK2 in inhibitory proliferation was analyzed by qRT-PCR,Western blotting and immunohistochemistry.Results Compared with normal renal epithelial tissues,DKK2 mRNA was down-regulated in children with nephroblastoma,and the difference was statistically significant(P＜0.001).Compared with the control group,transfected DKK2 cell viability was significantly inhibited after treatment for 24,48 and 72h(P＜0.05),cell clone formation in the experimental group was significantly inhibited(31.11%±2.14%)(P＜0.05),the cell cycle in the experimental group was significantly arrested at the G1 phase(P＜0.001),and the apoptosis rate in the experimental group was significantly increased(P＜0.001).Compared with the control group,the tumor weight and volume in nude mice were significantly low in the experimental mice which were injected DKK2 overexpression cells(P＜0.001).Active-β-catenin and downstream genes were significantly inhibited in over-expressed DKK2 SK-NEP-1 cells.Conclusion DKK2 is down-regulated in human cutaneous nephroblastoma and participates in the mechanism of nephroblastoma by antagonizing Wnt/β-catenin signaling pathway.

Key words: Nephroblastoma, DKK2, Tumor suppressor genes, Cell proliferation, Wnt/β-catenin

中图分类号:

R737

袁桂霞, 李岩, 冯婉琪, 夏小娟, 李旭. 抑癌基因DKK2抑制儿童肾母细胞瘤细胞增殖的机制研究[J]. 实用肿瘤学杂志, 2019, 33(1): 14-20.

YUAN Guixia, LI Yan, FENG Wanqi, XIA Xiaojuan, LI Xu. Mechanism of tumor suppressor gene DKK2 inhibiting proliferation of nephroblastoma cells in children[J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 14-20.

参考文献

1 Perme MP,Jereb B.Trends in survival after childhood cancer in Slovenia between 1957 and 2007[J].Pediatr Hematol Oncol,2009,26(4):240-251.
2 Schimke RN,Collins DL,Stolle CA.Paraganglioma,neuroblastoma,and a SDHB mutation:Resolution of a 30-year-old mystery[J].Am J Med Genet A,2010,152(6):1531-1535.
3 Wang C,Yue Y,Shao B,et al.Dickkopf-related protein 2 is epigenetically inactivated and suppresses colorectal cancer growth and tumor metastasis by antagonizing Wnt/β-catenin signaling[J].Cell Physiol Biochem,2017,41(5):1709-1724.
4 You A,Fokas E,Wang LF,et al.Expression of the Wnt antagonist DKK2 is frequently suppressed in sporadic epithelial ovarian cancer[J].J Cancer Res Clin Oncol,2011,137(4):621-627.
5 Chikara S,Lindsey K,Dhillon H,et al.Enterolactone induces G₁-phase cell cycle arrest in non small cell lung cancer cells by downregulating cyclins and cyclin-dependent kinases[J].Nutr Cancer,2017,69(4):652-662.
6 Pothoven KL,Schleimer RP.The barrier hypothesis and Oncostatin M:Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease[J].Tissue Barriers,2017,5(3):e1341367.
7 Wong SHM,Fang CM,Chuah LH,et al.E-cadherin:Its dysregulation in carcinogenesis and clinical implications[J].Crit Rev Oncol Hematol,2018,121:11-22.
8 Han B,Zhou B,Qu Y,et al.FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer[J].Oncogene,2018,37(10):1399-1408.
9 Fatima I,El-Ayachi I,Taotao L,et al.The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer[J].PLoS One,2017,12(12):e0189864.
10 Li C,Lyu J,Meng QH.MiR-93 Promotes Tumorigenesis and metastasis of non-small cell lung cancer cells by activating the PI3K/Akt pathway via inhibition of LKB1/PTEN/CDKN1A[J].J Cancer,2017,8(5):870-879.
11 You A,Fokas E,Wang LF,et al.Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer[J].J Cancer Res Clin Oncol,2011,137(4):621-627.
12 Pothoven KL,Schleimer RP.The barrier hypothesis and Oncostatin M:Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease[J].Tissue Barriers,2017,5(3):e1341367.
13 Ying Y,Qingwu L,Mingming X,et al.Emodin:one main ingredient of Shufeng Jiedu Capsule reverses chemoresistance of lung cancer cells through inhibition of EMT[J].Cell Physiol Biochem,2017,42(3):1063-1072.
14 Katase N,Nishimatsu SI,Yamauchi A,et al.DKK3 overexpression increases the malignant properties of head and neck squamous cell carcinoma cells[J].Oncol Res,2018,26(1):45-58.
15 Al-Dhohorah T,Mashrah M,Yao Z,et al.Aberrant DKK2 expression in the oral leukoplakia and oral submucous fibrosis:a comparative immunohistochemical study[J].Eur J Histochem,2016,60(2):2629.

[1]	秦文,赵楠楠,韩永焕,徐亚君. ZNF436在胃癌中的表达及调控WNT/β-catenin对胃癌细胞迁移及侵袭的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 222-227.
[2]	白晓斌, 霍龙伟, 谢万福, 徐高峰, 王茂德. Chk1在胶质母细胞瘤中的表达及其与肿瘤生物学行为和预后生存的关联性[J]. 实用肿瘤学杂志, 2019, 33(2): 122-127.
[3]	卞秀森, 李光, 关欣宇, 张伊, 狄畅, 马璨. UHRF1通过调控细胞自噬抑制肺腺癌细胞增殖的分子机制研究[J]. 实用肿瘤学杂志, 2018, 32(6): 498-502.
[4]	刘娟综述, 张澍田审校. 细胞周期蛋白依赖性激酶抑制因子3在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 575-578.
[5]	陈鳞, 王恩湘, 刘群友, 钟鹰, 周国良, 赵喜雁. CDX2基因通过NF-κB信号通路抑制结肠癌细胞增殖[J]. 实用肿瘤学杂志, 2018, 32(5): 398-403.
[6]	麦威, 宋春雨, 于洪文, 王新成, 郭阳, 曲国蕃. GSK3β对骨肉瘤细胞增殖的影响[J]. 实用肿瘤学杂志, 2015, 29(6): 487-491.
[7]	邢晓静, 谷小虎, 肖景东. Biglycan及FAK信号通路对结肠癌细胞增殖能力的影响及分子机制[J]. 实用肿瘤学杂志, 2015, 29(5): 428-431.
[8]	崔滨滨, 刘彦龙, 陈洪生, 周飞, 于雪峰, 徐海涛. 抑癌基因ING3在大肠癌中表达及意义[J]. 实用肿瘤学杂志, 2014, 28(6): 481-484.
[9]	刘跃欣, 周琪, 闫金银综述, 胡万宁审校. 蒜素抗肿瘤的研究进展[J]. 实用肿瘤学杂志, 2014, 28(6): 557-560.
[10]	薛伟男,张干,杨艳梅,马玉彦,孙根,崔滨滨. 抑癌基因ING1在大肠癌中的表达及预后意义[J]. 实用肿瘤学杂志, 2014, 28(5): 385-390.
[11]	顾红媛综述樊立华审校. 宫颈癌致病危险因素的研究进展[J]. 实用肿瘤学杂志, 2014, 28(4): 367-370.
[12]	罗卫综述,赵晓平审校. Mfn2/HSG与恶性肿瘤[J]. 实用肿瘤学杂志, 2013, 27(5): 457-459.
[13]	张洪峰,章艳,苏慧. 蝙蝠葛酚性碱对胃癌细胞SGC-7901增殖作用的实验研究[J]. 实用肿瘤学杂志, 2013, 27(2): 116-119.
[14]	张艳伟, 马晓欣. 新抑癌基因——TSLC1和DAL-1/4.1B与恶性肿瘤的关系[J]. 实用肿瘤学杂志, 2012, 26(6): 559-563.
[15]	李欣, 张丽杰, 任云会. 抑癌基因ING1在乳腺癌中的表达及其临床[J]. 实用肿瘤学杂志, 2011, 25(3): 207-211.